Skip to main content
. 2024 Nov 14;13(11):1391. doi: 10.3390/antiox13111391

Figure 3.

Figure 3

Immune function in peripheral blood leukocytes of participants in the placebo and supplement groups before and after the treatment. (A) Neutrophil chemotaxis (chemotaxis index). (B) Phagocytic capacity of neutrophils (phagocytic index). (C) Lymphocyte chemotaxis (chemotaxis index). (D) Lymphoproliferation in response to PHA (c.p.m). * p < 0.05, ** p < 0.01 compared to the initial condition. PHA: phytohemagglutinin; c.p.m: counts per minute.